Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction.

Kastrati A, Dibra A, Spaulding C, Laarman GJ, Menichelli M, Valgimigli M, Di Lorenzo E, Kaiser C, Tierala I, Mehilli J, Seyfarth M, Varenne O, Dirksen MT, Percoco G, Varricchio A, Pittl U, Syvänne M, Suttorp MJ, Violini R, Schömig A.

Eur Heart J. 2007 Nov;28(22):2706-13. Review.

2.

Drug-eluting stents versus bare-metal stents in diabetic patients with ST-segment elevation acute myocardial infarction: a pooled analysis of individual patient data from seven randomized trials.

Iijima R, Byrne RA, Dibra A, Ndrepepa G, Spaulding C, Laarman GJ, Menichelli M, Valgimigli M, Di Lorenzo E, Kaiser C, Tierala I, Mehilli J, Suttorp MJ, Violini R, Schömig A, Kastrati A.

Rev Esp Cardiol. 2009 Apr;62(4):354-64. Review. English, Spanish.

3.

Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized clinical trials.

Piscione F, Piccolo R, Cassese S, Galasso G, Chiariello M.

Catheter Cardiovasc Interv. 2009 Aug 1;74(2):323-32. doi: 10.1002/ccd.22017. Review.

PMID:
19360858
4.
5.

The effect of drug-eluting stents on intermediate angiographic and clinical outcomes in diabetic patients: insights from randomized clinical trials.

Kumbhani DJ, Bavry AA, Kamdar AR, Helton TJ, Bhatt DL.

Am Heart J. 2008 Apr;155(4):640-7. doi: 10.1016/j.ahj.2007.11.017. Review.

PMID:
18371470
6.

Meta-analysis of long-term outcomes for drug-eluting stents versus bare-metal stents in primary percutaneous coronary interventions for ST-segment elevation myocardial infarction.

Wallace EL, Abdel-Latif A, Charnigo R, Moliterno DJ, Brodie B, Matnani R, Ziada KM.

Am J Cardiol. 2012 Apr 1;109(7):932-40. doi: 10.1016/j.amjcard.2011.11.021. Review.

PMID:
22221949
7.

A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease.

Schömig A, Dibra A, Windecker S, Mehilli J, Suárez de Lezo J, Kaiser C, Park SJ, Goy JJ, Lee JH, Di Lorenzo E, Wu J, Jüni P, Pfisterer ME, Meier B, Kastrati A.

J Am Coll Cardiol. 2007 Oct 2;50(14):1373-80. Review.

10.

Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials.

De Luca G, Dirksen MT, Spaulding C, Kelbaek H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser C, Musto C, Chechi T, Spaziani G, Díaz de la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Cortese G, Suryapranata H, Stone GW; Drug-Eluting Stent in Primary Angioplasty (DESERT) Cooperation..

Arch Intern Med. 2012 Apr 23;172(8):611-21; discussion 621-2. doi: 10.1001/archinternmed.2012.758. Review.

PMID:
22529227
11.

Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction.

Pasceri V, Patti G, Speciale G, Pristipino C, Richichi G, Di Sciascio G.

Am Heart J. 2007 May;153(5):749-54. Review.

PMID:
17452148
12.

Drug-eluting stents for ST[corrected]-elevation acute myocardial infarction: do we need randomized trials?

Ryan J, Cohen DJ, Pinto DS.

Coron Artery Dis. 2006 Dec;17(8):667-71. Review. Erratum in: Coron Artery Dis. 2007 Mar;18(2):149.

PMID:
17119374
13.

Safety and efficacy of drug-eluting stents versus bare-metal stents in saphenous vein grafts lesions: a meta-analysis.

Sanchez-Recalde A, Jiménez Valero S, Moreno R, Barreales L, Lozano I, Galeote G, Martín Reyes R, Calvo L, Lopez-Sendon JL.

EuroIntervention. 2010 May;6(1):149-60. doi: 10.4244/. Review.

PMID:
20542811
14.

Clinical outcomes of dialysis patients after implantation of DES: meta analysis and systematic review of literature.

Athappan G, Ponniah T.

Minerva Cardioangiol. 2009 Jun;57(3):291-7. Review.

PMID:
19513010
15.

Drug-eluting stents for acute myocardial infarction.

Yeter E, Kurt M, Silay Y, Anderson HV, Denktas AE.

Expert Opin Pharmacother. 2009 Jan;10(1):19-34. doi: 10.1517/14656560802627952 . Review.

PMID:
19236180
16.

Stent choice in primary percutaneous coronary intervention: drug-eluting stents or bare metal stents?

Valgimigli M, Airoldi F, Zimarino M.

J Cardiovasc Med (Hagerstown). 2009 Oct;10 Suppl 1:S17-26. doi: 10.2459/01.JCM.0000362040.25767.f5. Review.

PMID:
19851216
17.

Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis.

Brar SS, Leon MB, Stone GW, Mehran R, Moses JW, Brar SK, Dangas G.

J Am Coll Cardiol. 2009 May 5;53(18):1677-89. doi: 10.1016/j.jacc.2009.03.013. Review.

18.

Drug-eluting versus bare metal stenting in acute myocardial infarction. A clinical review.

Jones WS, Washam JB, Meine TJ, Patel MR.

Minerva Cardioangiol. 2009 Oct;57(5):585-95. Review. Erratum in: Minerva Cardioangiol. 2009 Dec;57(6):830. Schuyler Jones, W [corrected to Jones, W S].

PMID:
19838149
19.

Meta-analysis of five randomized clinical trials comparing sirolimus- versus paclitaxel-eluting stents in patients with diabetes mellitus.

Zhang F, Dong L, Ge J.

Am J Cardiol. 2010 Jan 1;105(1):64-8. doi: 10.1016/j.amjcard.2009.08.652. Review.

PMID:
20102892
20.

Safety and efficacy of drug-eluting stents compared with bare metal stents in ST-elevation myocardial infarction.

Beattie MJ, Lee MS.

Rev Cardiovasc Med. 2010 Spring;11(2):57-73. Review.

PMID:
20700088
Items per page

Supplemental Content

Support Center